Burkitt Lymphoma
Showing 4626 - 4650 of 5,429
Lymphoma Trial in Shanghai (nucleoside analog reverse transcriptase inhibitor)
Unknown status
- Lymphoma
- nucleoside analog reverse transcriptase inhibitor
-
Shanghai, Shanghai, China
- +1 more
Jan 7, 2014
Chronic Myeloproliferative Disorders, Leukemia, Lymphoma Trial in Zion (carboplatin, docetaxel, ifosfamide)
Completed
- Chronic Myeloproliferative Disorders
- +6 more
- carboplatin
- +5 more
-
Zion, IllinoisMidwestern Regional Medical Center
Mar 25, 2013
Osteonecroses in Pediatric Patients With ALL
Unknown status
- Osteonecrosis
- +2 more
-
Aachen, Germany
- +24 more
Mar 4, 2014
Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia in
Withdrawn
- Accelerated Phase Chronic Myelogenous Leukemia
- +102 more
- management of therapy complications
- musculoskeletal complications management/prevention
- (no location specified)
Jul 5, 2012
Malignant Solid Tumor, Lymphomas, Multiple Myeloma Trial in Scottsdale, Columbus, San Antonio (AV-299, AV-299 + erlotinib)
Completed
- Malignant Solid Tumor
- +2 more
- AV-299
- AV-299 + erlotinib
-
Scottsdale, Arizona
- +2 more
Jan 23, 2014
Lymphoma Follow-up
Completed
- Lymphoma
-
Baltimore, MarylandNIA Clinical Research Unit
Dec 19, 2013
Esophageal Cancer, Lung Cancer, Lymphoma Trial in Madison (topotecan HCl, low-LET electron therapy, low-LET photon therapy)
Completed
- Esophageal Cancer
- +2 more
- topotecan hydrochloride
- +2 more
-
Madison, WisconsinUniversity of Wisconsin Comprehensive Cancer Center
Feb 8, 2013
Lymphoma, Solid Tumor Trial in Baltimore (chemo, oral sodium phenylbutyrate)
Completed
- Lymphoma
- Unspecified Adult Solid Tumor, Protocol Specific
- chemotherapy
- oral sodium phenylbutyrate
-
Baltimore, MarylandJohns Hopkins Oncology Center
Feb 4, 2013
Lymphoma Trial in Japan (Fludarabine Phosphate (Fludara))
Completed
- Lymphoma
- Fludarabine Phosphate (Fludara)
-
Nagoya-shi, Aichi, Japan
- +16 more
Dec 2, 2013
Lymphoma Trial in Cleveland (iodine I 131 mAb Lym-1)
Completed
- Lymphoma
- iodine I 131 monoclonal antibody Lym-1
-
Cleveland, OhioIreland Cancer Center
Jan 8, 2014
Lymphoma Trial in East Melbourne, Plymouth (rituximab, cyclophosphamide, fludarabine phosphate)
Completed
- Lymphoma
- rituximab
- +2 more
-
East Melbourne, Victoria, Australia
- +1 more
Dec 17, 2013
Non-Hodgkin Lymphoma Trial in Worldwide (doxycycline (tetracycline))
Completed
- Non-Hodgkin Lymphoma
- doxycycline (tetracycline)
-
Providencia, Santiago, Chile
- +5 more
Nov 22, 2013
Lymphoma Trial in Cleveland (biological, drug, procedure, radiation)
Completed
- Lymphoma
- filgrastim
- +6 more
-
Cleveland, OhioCleveland Clinic Taussig Cancer Institute, Case Comprehensive Ca
Oct 28, 2013
Leukemia, Lymphoma, MDS Trial in Cleveland (drug, radiation, procedure)
Completed
- Leukemia
- +3 more
- busulfan
- +5 more
-
Cleveland, OhioCase Medical Center, University Hospitals Seidman Cancer Center,
Jun 19, 2013
DLBCL Trial in Gent (VELCADE, Rituximab, Cyclophosphamide)
Completed
- Diffuse Large B-Cell Lymphoma
- VELCADE
- +5 more
-
Gent, BelgiumUniversitair Ziekenhuis Gent - UZ GENT, Hematologie, 9K12IE 9de
Dec 11, 2013
Expression of Glycine/ Serine Pathway Molecules in Solid Tumors
Unknown status
- Solid Tumor Cancer
-
Singapore, SingaporeNationa University Hospital
Apr 1, 2014
Drug/Agent Toxicity by Tissue/Organ, Lymphoma, Neutropenia Trial in Chicago (cyclosporine, irinotecan HCl, phenobarbital)
Completed
- Drug/Agent Toxicity by Tissue/Organ
- +4 more
- cyclosporine
- +2 more
-
Chicago, IllinoisUniversity of Chicago Cancer Research Center
Feb 4, 2013
MALT Lymphoma Trial (Bortezomib (Velcade))
Completed
- MALT Lymphoma
- Bortezomib (Velcade)
- (no location specified)
Nov 26, 2013
Lymphoma Trial in United States (filgrastim, rituximab, carboplatin)
Terminated
- Lymphoma
- filgrastim
- +4 more
-
Mobile, Alabama
- +84 more
Apr 8, 2013